Squinto Stephen P
SEC-identified person · CIK 1231954 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Springworks Therapeutics, Inc. [SWTX | Director | filed 2019 - 2022 |
| Olivia Ventures, Inc. CMPX | Director | filed 2020 - 2022 |
| Chemomab Therapeutics Ltd. CMMB | Director | filed 2021 - 2021 |
| Passage BIO, Inc. PASG | Director · Head of Research and Dev | filed 2020 - 2020 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016 - 2017 |
| Alexion Pharmaceuticals, INC. alxn | EVP, Research and Development | filed 2006 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.